Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: naturalperson who wrote (7542)	8/5/2005 10:09:12 AM
From: pictouislander	Read Replies (1) \| Respond to of 8117

I have been around along time and its nice to here fresh exciting talk.But i have heard it all before in my opinion i hope they concentrate on just the Fast 1.No offense natural but lets not get to far ahead of things.

To: naturalperson who wrote (7542)	8/5/2005 10:37:39 AM
From: Jack Rayfield	Respond to of 8117

I agree with naturalperson I think that additional/complimentary products are essential to Pyng long range future. They are already developing a mulit-use version of the FAST1 which is essential to revenue growth as the market is limited for US$125 a shot second option protocol devices. Regardless of how great the product is and how sure the access an EMT is not going to opt for a FAST1 over a US$5 IV unless there is no other alternative. As I have said before I think the maximum sales potential of the FAST1 single use product is 250K worldwide. But the potential for a multi-use version that costs US$30 a use (5 catheter chamber on a US$150 FAST1) is probably more than 6 times this amount as Medical Directors will probably be able to justify the increased use based on urgency and increased reliable access. I also agree that Pyng should pursue licensing/ purchasing complementary products with the cashflow that will be kicked off. Their established distributor network and experience bringing a completely new product to market should be leveraged. Though I think that this is a longer range avenue say 3 to 5 years because I also agree with kimball93 I want Pyng to concentrate on making Pyng Technologies as profitable as possible for next couple years to get the stock price inline with the potential. But they should be actively evaluating potential products that would be a good fit.